Tweaking a protein expressed by most liver cancer cells has enabled scientists to make a vaccine that is exceedingly effective at preventing the disease in mice.
Alpha-Fetoprotein, or AFP – normally expressed during development and by liver cancer cells as well – has escaped attack in previous vaccine iterations because the body recognizes it as “self,” said Dr. Yukai He, immunologist at the Medical College of Georgia and Georgia Regents University Cancer Center.
Liver cancer is among the fastest-growing and deadliest cancers in the United States with a 17 percent three-year survival rate. Vaccines help direct the immune system to attack invaders by showing it a representative substance, called an antigen, that the body will recognize as foreign, in this case, AFP for liver cancer.
Read more . . .
The Latest on: Liver cancer
[google_news title=”” keyword=”Liver cancer” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Liver cancer
- Lifestyle related liver disorder- The rise and rise of Fatty liver disease!on April 25, 2024 at 7:30 am
Rising liver disorders in India due to poor diets, alcohol, stress causing fatty liver, inflammation, scarring, cancer. Patients underestimate severit ...
- Pediatric cancer survivor becomes nurse, works with LVHN nurse who cared for heron April 25, 2024 at 2:02 am
A Lehigh Valley nurse and her former patient are back together again, but this time, they are both taking care of those who need them.
- Study identifies driver of liver cancer that could be target for treatmenton April 25, 2024 at 2:00 am
Inhibiting a certain protein in mice reduced obesity-induced liver tumor development, Yale researchers found. It could reveal a future treatment route.
- Long-term Complete Response to Can-Fite's Namodenoson in Patient with Advanced Liver Cancer: Article Published in a Leading Scientific Journalon April 25, 2024 at 12:00 am
The patient participated in the Phase II Liver Cancer Study and has been treated with namodenoson for >7 years under compassionate use program. The article describes a patient with advanced liver ...
- Stop hepatitis infection to curb increasing liver cancer cases —Otegbayo, UCH, chief medical directoron April 24, 2024 at 7:31 pm
In a bid to stop the hepatitis B virus, the leading cause of liver cancer, a liver expert, Professor Jesse Otegbayo, has stated the need to identify the factors that encourage the spread of hepatitis ...
- Study identifies molecular pathway in liver cancer developmenton April 23, 2024 at 3:16 pm
As a malignant disease of the liver cells, hepatocellular carcinoma (HCC) is one of the main causes of cancer-related deaths. While the treatment options for this aggressive type of cancer remain ...
- Liver cancer: Molecular signaling pathway of tumor development decodedon April 23, 2024 at 9:25 am
As a malignant disease of the liver cells, hepatocellular carcinoma (HCC) is one of the main causes of cancer-related deaths. While the treatment options for this aggressive type of cancer remain ...
- WOO Network trials investigate innovative treatments for liver, head and neck cancerson April 20, 2024 at 10:44 pm
A new round of clinical trials supported by the Ontario Institute for Cancer Research (OICR) will harness a unique opportunity to test some of the newest treatment strategies for a range of different ...
- Signs and Symptoms of Liver Canceron April 18, 2024 at 5:00 am
Liver cancer occurs when cancer cells begin to grow abnormally and form tumors in the liver. Your liver is the largest internal organ in your body and is responsible for breaking down and storing ...
- Signs and Symptoms of Liver Canceron April 18, 2024 at 5:00 am
Liver cancer causes cancer cells to grow out of control, causing symptoms like abdominal pain and swelling as the disease progresses to later stages.
via Bing News